- Update: Wake me up when September ends…Hansi Flick might be down to last chance with Germany Bavarian Football Works
- Hansi Flick remains Germany coach only by default as they continue to flounder The Athletic
- German newspaper starts campaign for Jürgen Klopp to become Germany coach CaughtOffside
- Rudi Völler calls for patience with the German national football team Bavarian Football Works
- Germany in tailspin one year from Euro 2024: Booed off after Colombia defeat, pressure mounting on coach Hansi Flick Sky Sports
- View Full Coverage on Google News
Tag Archives: September
Intel To Host Innovation 2023 Event on 19th September: Meteor Lake, Raptor Lake Refresh & Alchemist+ Expected – Wccftech
- Intel To Host Innovation 2023 Event on 19th September: Meteor Lake, Raptor Lake Refresh & Alchemist+ Expected Wccftech
- Efficient Intel Meteor Lake described as “Zen 4 Phoenix Killer” as leak claims Intel is working on a 40-core Arrow Lake CPU Notebookcheck.net
- Intel Innovation 2023 set for September 19, Raptor Lake Refresh launch? VideoCardz.com
- Intel’s Innovation 2023 conference revealed for September 19-20 Neowin
- Intel Panther Lake and Beast Lake leak suggests up to 40% more single-core performance vs Arrow Lake for former and Extra Big cores for latter Notebookcheck.net
- View Full Coverage on Google News
Intel Innovation 2023 set for September 19, Raptor Lake Refresh launch? – VideoCardz.com
- Intel Innovation 2023 set for September 19, Raptor Lake Refresh launch? VideoCardz.com
- Efficient Intel Meteor Lake described as “Zen 4 Phoenix Killer” as leak claims Intel is working on a 40-core Arrow Lake CPU Notebookcheck.net
- Intel Beast Lake: 10 performance cores and huge clocks to beat AMD’s X3D CPUs? TweakTown
- Intel’s Innovation 2023 conference revealed for September 19-20 Neowin
- Intel Panther Lake and Beast Lake leak suggests up to 40% more single-core performance vs Arrow Lake for former and Extra Big cores for latter Notebookcheck.net
- View Full Coverage on Google News
Fox goes all in on Deion Sanders’ Colorado football team, at least in September – The Athletic
- Fox goes all in on Deion Sanders’ Colorado football team, at least in September The Athletic
- Nebraska Football: Deion Sanders sends a warning to opponents Husker Corner
- Deion Sanders’ Spring Game debut raked in a nice profit for school: ‘It was a good day for Colorado athletics’ Fox News
- Pac-12 early-season schedule features one game on streaming, another on Sunday and two Big Noon appearances The Mercury News
- College football early TV schedule coming into focus with Deion Sanders, Colorado getting major spotlight Yahoo Sports
- View Full Coverage on Google News
Marvel’s Avengers to be Delisted in September as Development Comes to an End
A little more than two years after its original release, Crystal Dynamics is preparing to end active development on Marvel’s Avengers.
According to a blog titled “Final Update on the Future of Marvel’s Avengers,” support will discontinue on September 30, after which digital purchases will no longer be available. All solo content will continue to be playable after support ends, and multiplayer will also remain available.
An important announcement about the future of Marvel’s Avengers: https://t.co/hTmenK6wmJ pic.twitter.com/JVZNNDNzZy
— Marvel’s Avengers (@PlayAvengers) January 20, 2023
Crystal Dynamics does not plan to release any new stories, features, or Heroes, making Update 2.7 — which added the Winter Soldier and the Cloning Lab Omega-Level Threat — the final content release for Avengers. Spider-Man will remain a PlayStation exclusive.
The final balance update will be Update 2.8, which will be released March 31. Crystal Dynamics does not plan to release any new stories, features, or Heroes. Afterward, Crystal Dynamics says it will turn off the cosmetics marketplace and credits will no longer be purchasable. Credits balances will be converted into in-game resources, and all cosmetics will be made available for free.
“We know this is disappointing news as everyone in our community has such a connection to these characters and their stories,” Crystal Dynamics wrote. “We’re so, so grateful that you came on this adventure with us. Your excitement for Marvel’s Avengers — from your epic Photo Mode shots, to your threads theorizing who our next Heroes would be, to your Twitch streams — has played a large part in bringing this game to life.”
A mighty disappointment
We called Marvel’s Avengers one of E3 2019’s biggest disappointments when it was first revealed, and it fared little better when it released the following year, earning middling reviews from players and critics alike. It soon saw a major drop in player count as players grew bored and moved on.
Crystal Dynamics continued to release new content, including several new characters, but it never regained momentum after its troubled launch.
Community insider Miller Ross first broke the news that Marvel’s Avengers would be shutting down and that the team would be moved to Amazon Games’ Tomb Raider project. The report also claims that Crystal Dynamics fired lead designer Brian Waggoner after a series of racist tweets from 2014 were unearthed in November.
Reached for comment on the report, Crystal Dynamics provided a link to the blog and did not issue any further statement.
Development…
Kat Bailey is a Senior News Editor at IGN as well as co-host of Nintendo Voice Chat. Have a tip? Send her a DM at @the_katbot.
Mortgage rates fall to lowest level since September
DeBianchi Real Estate’s Sam DeBianchi discusses mortgage rates and shares her outlook for the housing market into next year.
Mortgage rates continued to fall this week to their lowest levels since September as the latest round of economic data showed signs that inflation is starting to cool.
The average rate on a 30-year fixed mortgage fell to 6.15% on Thursday from 6.33% last week, according to mortgage buyer Freddie Mac. A year ago, the average rate was 3.56%.
“As inflation continues to moderate, mortgage rates declined again this week,” Freddie Mac chief economist Sam Khater said. “Rates are at their lowest level since September of last year, boosting both homebuyer demand and homebuilder sentiment.”
Contractors work on a home under construction in Antioch, California, US, on Tuesday, June 14, 2022. (Photographer: David Paul Morris/Bloomberg via Getty Images / Getty Images)
STUDY CLAIMS WEALTHY BLUE STATE IS AMERICA’S MOST AFFORDABLE, BEATING STATES THOUSANDS ARE MOVING TO
“Declining rates are providing a much-needed boost to the housing market, but the supply of homes remains a persistent concern,” Khater added.
Meanwhile, the average rate on a 15-year fixed mortgage fell to 5.28% from last week when it averaged 5.52%. A year ago, it averaged 2.79%.
The big rise in mortgage rates during the past year has throttled the housing market, with sales of existing homes falling for 10 straight months to the lowest level in more than a decade.
US REAL ESTATE MARKET IN ‘BIG TROUBLE,’ EXPERT WARNS
Local real estate business is down slightly from this time last year.Home Sales Wf 2
Though inflation at the consumer level has declined for six straight months, Fed officials have signaled that they may raise the central bank’s main borrowing rate another three-quarters of a point in 2023, which would be in a range of 5% to 5.25%.
CLICK HERE TO GET THE FOX BUSINESS APP
The Associated Press contributed to this report
BioNTech says it will start cancer vaccine trials in the UK from September
A NHS vaccinator administers the Pfizer-BioNTech Covid-19 booster jab to a woman, at a vaccination centre in London. BioNTech is launching a large-scale trial of mRNA therapies to treat cancer and other diseases in the U.K.
Sopa Images | Lightrocket | Getty Images
LONDON — The U.K. government on Friday announced a partnership with German firm BioNTech to test potential vaccines for cancer and other diseases, as campaigners warned any breakthrough must remain affordable and accessible.
Cancer patients in England will get early access to trials involving personalized mRNA therapies, including cancer vaccines, which aim to spur the immune system to attack harmful cells.
They will be administered to early and late-stage patients and target both active cancer cells and preventing their return.
BioNTech will set up new research and development centers in the U.K., with a lab in Cambridge and headquarters in London, and aim to deliver 10,000 therapies to patients from September 2023 until the end of the decade.
The company developed one of the most widely-distributed Covid-19 vaccines alongside U.S. pharma firm Pfizer. Its CEO, Ugur Sahin, said it had learned lessons from the coronavirus pandemic about collaboration between the British National Health Service, academics, regulators and the private sector in the development of drugs that it was applying now.
“Our goal is to accelerate the development of immunotherapies and vaccines using technologies we have been researching for over 20 years,” he said in a statement. “The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.”
Peter Johnson, Britain’s National Clinical Director for Cancer, said mRNA technology had the potential to transform approaches to a number of illnesses.
The government confirmed to CNBC the announcement represented a private investment into the U.K., but would be supported by a new Cancer Vaccine Launch Pad funded by the NHS.
Other mRNA cancer vaccines, including a collaboration between U.S. firms Moderna and Merck, are also being trialed.
Tim Bierley, a campaigner at U.K.-based group Global Justice Now, said big pharmaceutical companies had “terrible record of price gouging on new medicines, even where public money has played a key role in bringing them to the market.”
“The government has a moral duty to push BioNtech to set the price of this potentially life-saving vaccine so it is accessible to all,” he said.
Mohga Kamal-Yanni, policy co-lead for the People’s Vaccine Alliance — a global group of health organizations, economists and activists — said news of the trial was good, but that any outcome “belongs to the people” due to the amount of public funding involved.
“The U.K. government must say how it will ensure any new medicine, vaccine or technology will be made available and affordable to developing countries,” Kamal-Yanni said.
A government spokesperson told CNBC the research was at too early a stage to discuss pricing and distribution, but pointed to its record in distributing free Covid-19 vaccines.
BioNTech says it will start cancer vaccine trials in the UK from September
A NHS vaccinator administers the Pfizer-BioNTech Covid-19 booster jab to a woman, at a vaccination centre in London. BioNTech is launching a large-scale trial of mRNA therapies to treat cancer and other diseases in the U.K.
Sopa Images | Lightrocket | Getty Images
LONDON — The U.K. government on Friday announced a partnership with German firm BioNTech to test potential vaccines for cancer and other diseases, as campaigners warned any breakthrough must remain affordable and accessible.
Cancer patients in England will get early access to trials involving personalized mRNA therapies, including cancer vaccines, which aim to spur the immune system to attack harmful cells.
They will be administered to early and late-stage patients and target both active cancer cells and preventing their return.
BioNTech will set up new research and development centers in the U.K., with a lab in Cambridge and headquarters in London, and aim to deliver 10,000 therapies to patients from September 2023 until the end of the decade.
The company developed one of the most widely-distributed Covid-19 vaccines alongside U.S. pharma firm Pfizer. Its CEO, Ugur Sahin, said it had learned lessons from the coronavirus pandemic about collaboration between the British National Health Service, academics, regulators and the private sector in the development of drugs that it was applying now.
“Our goal is to accelerate the development of immunotherapies and vaccines using technologies we have been researching for over 20 years,” he said in a statement. “The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.”
Peter Johnson, Britain’s National Clinical Director for Cancer, said mRNA technology had the potential to transform approaches to a number of illnesses.
The government confirmed to CNBC the announcement represented a private investment into the U.K., but would be supported by a new Cancer Vaccine Launch Pad funded by the NHS.
Other mRNA cancer vaccines, including a collaboration between U.S. firms Moderna and Merck, are also being trialed.
Tim Bierley, a campaigner at U.K.-based group Global Justice Now, said big pharmaceutical companies had “terrible record of price gouging on new medicines, even where public money has played a key role in bringing them to the market.”
“The government has a moral duty to push BioNtech to set the price of this potentially life-saving vaccine so it is accessible to all,” he said.
Mohga Kamal-Yanni, policy co-lead for the People’s Vaccine Alliance — a global group of health organizations, economists and activists — said news of the trial was good, but that any outcome “belongs to the people” due to the amount of public funding involved.
“The U.K. government must say how it will ensure any new medicine, vaccine or technology will be made available and affordable to developing countries,” Kamal-Yanni said.
A government spokesperson told CNBC the research was at too early a stage to discuss pricing and distribution, but pointed to its record in distributing free Covid-19 vaccines.
Israel on alert for strep A, which has killed 151 in the UK since September
Israel’s Health Ministry has raised concerns about the spread of strep A, a bacteria that has recently caused 29 child deaths in the UK.
Streptococcus, widely known as strep, commonly causes a sore throat and flu-like symptoms. But in rare cases the bacteria becomes invasive, growing in blood or other organs, and can trigger a range of conditions.
These include meningitis, scarlet fever, toxic shock syndrome, and a flesh-eating disease called necrotizing fasciitis. These can cause serious illness and even death.
Scientists categorize different “groups” of streptococcus bacteria — which are indistinguishable to people who get infected — and the focus of the current concern is Group A, formally known as streptococcus pyogenes.
The World Health Organization recently announced that there is an increase in morbidity from invasive infections caused by strep A, but didn’t throw light on why it is happening. Its announcement was based on reports from at least five countries: the Netherlands, France, Ireland, Sweden and the United Kingdom.
Australia reported two child deaths from the bacteria on Friday. And in the UK, counting both child and adult mortality, there have now been 151 deaths from strep A infections since September, and the season is thought to still be in full swing. The UK death count for children, 29, already surpassed the number from the last intense season, in 2017 and 2018.
Streptococcus pyogenes bacteria, known as strep A (Dr_Microbe via iStock by Getty Images)
The epidemiology team at the Health Ministry wrote to doctors on Monday, saying that it was monitoring strep A and “saw fit to raise the awareness of the medical teams on the subject.”
It said that strains of strep A that were rare in the past have been on the rise, causing an “increase in invasive morbidity.” It noted that strep A cases declined in the thick of the pandemic, but rose in the second half of 2021 and were high through 2022.
Epidemiologist Hagai Levine (courtesy of Hebrew University)
Prof. Hagai Levine, Hebrew University epidemiologist and chairman of the Israeli Association of Public Health Physicians, told The Times of Israel that parents shouldn’t panic, but should be vigilant.
“It’s certainly another health condition parents should be alert to, alongside COVID-19, flu, RSV and others,” he said.
Medical authorities need to focus on “monitoring, surveillance and raising awareness,” he said, noting that when caught in good time, invasive strep A can be effectively treated with antibiotics.
The World Health Organization reported in its recent announcement on strep A that there were “no reports of increased antibiotic resistance,” leaving doctors optimistic about the ability of antibiotics to quash infections.
The strep A bacteria spreads through sneezes, coughs and skin contact. The people most at risk of an infection becoming invasive are the elderly and anyone with a weakened immune system, for example, those with long-term health conditions.
Levine said that parents should seek medical advice if their child is unresponsive, has a high fever, or exhibits unusual behavior. He acknowledged that it can be hard for parents to know if their child is seriously ill, but said they should “trust their instincts” and go to the doctor if their conduct is out of the ordinary.
The Health Ministry said in its letter that “an invasive infection is defined when there is penetration of the bacteria into sterile sites such as the circulatory system, the lungs, and soft tissues such as muscle and fat.” It stressed that “high vigilance can contribute to quick diagnosis.”
You’re a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel ten years ago – to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
FB.Event.subscribe('comment.create', function (response) { comment_counter++; if(comment_counter == 2){ jQuery.ajax({ type: "POST", url: "/wp-content/themes/rgb/functions/facebook.php", data: { p: "2918641", c: response.commentID, a: "add" } }); comment_counter = 0; } }); FB.Event.subscribe('comment.remove', function (response) { jQuery.ajax({ type: "POST", url: "/wp-content/themes/rgb/functions/facebook.php", data: { p: "2918641", c: response.commentID, a: "rem" } }); });
};
(function(d, s, id){
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) {return;}
js = d.createElement(s); js.id = id;
js.src = "https://connect.facebook.net/en_US/sdk.js";
fjs.parentNode.insertBefore(js, fjs);
}(document, 'script', 'facebook-jssdk'));
Read original article here
Judge fines Trump lawyers in Clinton case thrown out in September
The defamation suit accused 2016 Democratic presidential nominee Hillary Clinton and her allies of harming Trump with an orchestrated plan to spread false information that his campaign colluded with Russia. Middlebrooks, in dismissing the suit in September, had written that there were “glaring structural deficiencies in the plaintiff’s argument.”
Two of the Trump lawyers — Alina Habba and Peter Ticktin — signaled that they would appeal.
“We attempted to right a wrong, and our reward is a kick in the teeth,” Ticktin said in an email. “Ultimately, this will be decided by a panel of three judges of the Eleventh Circuit Court of Appeals, as we believe that the dismissal and the sanctions which followed will ultimately be reversed.”
The other lawyers, Michael T. Madaio and Jamie Alan Sasson, did not immediately respond to email messages from The Post.
The fines are the latest legal setback for Trump. Federal officials are investigating him for taking sensitive government documents after leaving the White House, and officials in Manhattan are scrutinizing the financial records of his sprawling real estate business. Last month a federal judge in a separate case said Trump signed legal documents that he knew included false voter fraud numbers
The fines also come as Republicans and conservative media outlets have openly blamed Trump for Republicans underperforming in Tuesday’s midterm elections, which Trump had hoped would demonstrate his electoral clout ahead of an expected announcement next week that he would run for president in 2024.
In the lawsuit, Trump’s lawyers had inaccurately described Dolan in court papers as a former chairman of the Democratic National Committee, a senior official in the Clinton campaign and a close associate and adviser of Clinton. Trump’s lawsuit also accused Dolan, a public relations executive, of helping create a “dossier” of false information intended to smear Trump.
In response, a lawyer for Dolan demanded that his client be removed from the lawsuit, noting in court papers that Dolan did not participate in the creation of the dossier, had never been a chairman of the DNC, and said that his role in the campaign was, as Middlebrooks wrote, “limited to knocking on doors as a volunteer.”
Clinton, through a spokesperson, denied even knowing him, Middlebrooks wrote.
Trump’s lawyers then amended their complaint but did not substantively change their claims about Dolan, the judge wrote. The amended complaint referred to Dolan as a former chairman of a “national Democratic political organization,” and a “senior Clinton campaign official,” Middlebrooks wrote. Criticisms about this amended complaint were “unheeded,” the judge wrote.
In levying the fines against Trump’s lawyers, Middlebrooks cited Rule 11 of the Federal Rules of Civil Procedure which, the judge wrote, is meant to deter “attorneys and litigants from clogging federal courts with frivolous filings.”
Middlebrooks wrote that penalties under that rule are necessary when a party files a pleading “that has no reasonable factual basis,” is “based on a legal theory that has no reasonable chance of success,” or when a pleading is filed “in bad faith.”
“Here, all three are true,” Middlebrooks wrote. Later, he added, “The pleadings in this case contained factual allegations that were either knowingly false or made in reckless disregard for the truth.”
As an example, Middlebrooks highlighted a detail presented by Trump’s lawyers that said Dolan was a resident of Florida. Dolan’s lawyer noted his client was a resident of Virginia and did not do any campaign work in Florida.
Trump’s lawyers responded, bizarrely, in the amended complaint that Dolan was a resident of New York and that “Charles Dolan is an incredibly common name, and Plaintiff’s counsel’s traditional search methods identified countless individuals with said name across the country, many of whom reside in New York.”